Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02236620
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
RHS | 3-(CARBOXYAMIDE(2-CARBOXYAMIDE- 2-TERTBUTYLETHYL))PENTAN | A | 1JLD | 0.82 | |
RIN | 3-AMINO-AZACYCLOTRIDECAN-2-ONE | A,B | 1KBC | 0.79 | |
MNV | N-METHYL-C-AMINO VALINE | C | 1CWJ | 0.8 | |
A3M | 2-AMINO-3-METHYL-1-PYRROLIDIN-1- YL-BUTAN-1-ONE | A,B | 1N1M | 0.8 | |
1AD | (1S)-2-[(2S,5R)-2-(AMINOMETHYL)- 5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]- 1-CYCLOPENTYL-2-OXOETHANAMINE | A | 2GBG | 0.74 | |
AIO | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2EEP | 0.86 | |
AIO | [(2R)-1-(L-ALANYL-L-ISOLEUCYL)PYRROLIDIN- 2-YL]BORONIC ACID | A | 2Z3Z | 0.86 | |
BPR | (2R)-N-[(2R)-2-(DIHYDROXYBORYL)- 1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)- 5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN- 2-YL]-L-PROLINAMIDE | A,B,C,D | 2AJD | 0.77 | |
OHM | 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3- YL]DODECANAMIDE | B,H | 2NTF | 0.71 | |
ZRG | N~2~-acetyl-N-methyl-N~5~-[N-(methylcarbamoyl)carbamimidoyl]- L-ornithinamide | A,B | 3CHC | 0.75 | |
CLE | LEUCINE AMIDE | D | 1D5Z | 0.76 | |
CLE | LEUCINE AMIDE | C,D,E,F | 1QZ0 | 0.76 | |
CLE | LEUCINE AMIDE | C,D,E,F | 1XXV | 0.76 | |
CLE | LEUCINE AMIDE | A,D | 1D5M | 0.76 | |
CLE | LEUCINE AMIDE | C,D,E,F | 1XXP | 0.76 | |
BB1 | 2-[(FORMYL-HYDROXY-AMINO)-METHYL]- HEXANOIC ACID (1-DIMETHYLCARBAMOYL- 2,2-DIMETHYL-PROPYL)-AMIDE | A,B,C | 1G27 | 0.77 | |
SSM | (2S)-2-(acetylamino)-N-methyl-4- [(S)-methylsulfinyl]butanamide | A | 3BQF | 0.71 | |
PPL | PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1IDB | 0.81 | |
PPL | PIPERIDINE-2-CARBOXYLIC ACID TERT- BUTYLAMIDE | A,B | 1IDA | 0.81 | |
277 | N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)- 3-FLUOROPYRROLIDIN-1-YL]-1-METHYL- 3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE | A,B | 2OPH | 0.72 | |
CIB | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1- (1-FORMYL-PENTYLCARBAMOYL)-3-METHYL- BUTYL]-AMIDE | H,I,J,K,L,M,N | 1J2Q | 0.85 | |
AIA | (1S)-2-[(2S,5R)-2-(AMINOMETHYL)- 5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL- 2-OXOETHANAMINE | A | 2GBF | 0.71 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EDZ | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3EWJ | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2DDF | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B,C,D | 2I47 | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,C,E,I | 1BKC | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 2FV9 | 0.77 | |
INN | 3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]- 4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL- L-ALANINE | A,B | 3E8R | 0.77 | |
KCQ | (3S)-3-[(2S)-2-AMINO-3-OXOBUTYL]PYRROLIDIN- 2-ONE | A,I | 2Z3E | 0.73 | |
LPD | L-PROLINAMIDE | H,S | 2H9E | 0.75 | |
SP7 | N-{(1S)-3-[(4-aminobutyl)amino]- 1-methylpropyl}acetamide | A,B | 3CNP | 0.71 | |
GIO | CYCLO-(GLYCINE-L-PROLINE) INHIBITOR | A,B | 1W1P | 0.71 | |
LNO | L-LEUCYL-HYDROXYLAMINE | A | 4TLN | 0.73 | |
BAA | (TERT-BUTYLOXYCARBONYL)-ALANYL- ALANYL-AMINE | A | 1ELG | 0.72 | |
BUM | 2-AMINO-N,3,3-TRIMETHYLBUTANAMIDE | A,B | 1GKC | 0.77 | |
BUM | 2-AMINO-N,3,3-TRIMETHYLBUTANAMIDE | A,B | 1GKD | 0.77 |